DRIO (STOCKS)
DarioHealth Corp. Common Stock
$7.330000
-0.150000 (-2.01%)
Prev close: $7.480000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Medical Specialties
- CEO
- Erez Raphael
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $75.93M
- Employees
- 202
- P/E (TTM)
- -1.00
- P/B (TTM)
- 1.00
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Recent News
No recent news found for this ticker.
Financial Statements
| Revenues | $21.00M |
| Benefits Costs and Expenses | $56.20M |
| Cost Of Revenue | $8.79M |
| Costs And Expenses | $56.20M |
| Gross Profit | $12.21M |
| Nonoperating Income/Loss | -$3.37M |
| Operating Expenses | $44.05M |
| Research and Development | $10.45M |
| Other Operating Expenses | $33.60M |
| Operating Income/Loss | -$31.83M |
| Income/Loss From Continuing Operations After Tax | $16.19B |
| Income/Loss From Continuing Operations Before Tax | -$35.20M |
| Income Tax Expense/Benefit | $468.00K |
| Net Income/Loss | -$35.67M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$35.67M |
| Net Income/Loss Available To Common Stockholders, Basic | -$35.67M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | $6.13 |
| Diluted Earnings Per Share | $6.13 |
| Basic Average Shares | 20,373,183 |
| Diluted Average Shares | 20,373,183 |
| Assets | $96.59M |
| Current Assets | $22.13M |
| Inventory | $3.72M |
| Other Current Assets | $18.41M |
| Noncurrent Assets | $74.46M |
| Fixed Assets | $503.00K |
| Intangible Assets | $15.00M |
| Other Non-current Assets | $58.96M |
| Liabilities | $41.50M |
| Current Liabilities | $9.58M |
| Noncurrent Liabilities | $31.92M |
| Equity | $55.09M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $55.09M |
| Liabilities And Equity | $96.59M |
| Net Cash Flow From Operating Activities | -$25.35M |
| Net Cash Flow From Operating Activities, Continuing | -$25.35M |
| Net Cash Flow From Investing Activities | -$7.38M |
| Net Cash Flow From Investing Activities, Continuing | -$7.38M |
| Net Cash Flow From Financing Activities | $32.54M |
| Net Cash Flow From Financing Activities, Continuing | $32.60M |
| Exchange Gains/Losses | $31.00K |
| Net Cash Flow | -$203.00K |
| Net Cash Flow, Continuing | -$234.00K |
| Comprehensive Income/Loss | -$45.28M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$45.28M |
| Other Comprehensive Income/Loss | -$28.00M |